Trump backs bill to sanction China, India over Russian oil, US senator says | Russia-Ukraine war News

    Trump has ‘greenlit’ bipartisan push to sanction countries that buy Russian energy exports, Lindsey Graham says. Published On 8 Jan 20268 Jan 2026 Click here to share on social media share2 Share United States President Donald Trump has backed a bill to impose sanctions on countries that buy Russian oil, including China and India, an influential Republican senator has said….

    Read More
    Mark Cooper, Investment Partner at the UK Office for Investment, delivering his keynote presentation.

      UK unveils decade-long growth vision to Hong Kong investors

      [The content of this article has been produced by our advertising partner.] The UK set out its growth agenda in Hong Kong at the inaugural UK Investment Conference, where the country’s industrial strategy and sector opportunities in finance, life sciences, clean energy and advanced manufacturing were presented.  Hosted by the British Consulate-General Hong Kong on…

      Read More
      The LEAD framework teaching methodology has earned Professor Wu both the Faculty Teaching Excellence Awards 2022-23 (left) and the University Education Award 2024 (right)

        Leading students through open doors

        [The content of this article has been produced by our advertising partner.] Although her academic journey began at two of the world’s most prestigious institutions – first as an undergraduate at Peking University, then as a doctoral researcher at Stanford University – Professor Willow Wu has never allowed herself to be confined by the proverbial…

        Read More
        The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs

          The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs

          Hong Kong’s biotech fundraising momentum is expected to extend into 2026, as licensing deals and strong post-initial public offering (IPO) trading last year persuaded investors that China’s drug developers are worth backing again – even before they generate revenue. “Chinese innovation drugs expanding into overseas markets have become the industry mainstream, indicating the domestic innovation…

          Read More